{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.1436.1436",
    "article_title": "Rapid Screening of Targetable Kinase Gene Fusions in Acute Lymphoblastic Leukemia ",
    "article_date": "December 7, 2017",
    "session_type": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I",
    "abstract_text": "Background: Philadelphia-like (Ph-like) acute lymphoblastic leukemia (ALL) is a high-risk subtype characterized by a similar expression profiling to ALL with BCR-ABL rearrangement, but due to different genomic alterations that activate cytokine receptor and kinase signaling. Diagnose of this type of leukemia is challenging and current diagnostic algorithms include a combination of different techniques, most of them time-consuming and expensive. Here we present a multi-probe Fluorescence In Situ Hybridation (FISH)- Panel based screening test that permit a rapid diagnosis of ALL (including Ph-like ALL). Methods: We analysed 42 adolescent and adult patients (13 - 72 years old) diagnosed with ALL without BCR/ABL and KMT2A rearrangements. We performed a one-slide custom designed FISH panel in parallel with chromosome banding analysis. The panel included probes for ETV6/RUNX1, KMT2A, BCR/ABL1, E2A, CRLF2/P 2RY8, CSF1R, EPOR, PDGFRB, ABL2, JAK2, and IGH probes (Custom chromoprobe multiprobe ALL, Cytocell). Results: There were no hybridation failures. We identified 30 patients with alterations (71%), 20 of them (67%) with normal karyotype or without metaphases. The most common alterations were E2A deletion (8/30, 27%) [3 patients in a context of E2A/PBX rearrangement], hiperdiplid karyotype (6/30, 20%), ABL2 gain (5/30, 17%), CRLF2/IGH rearrangement (4/30, 13%), ETV6 deletion (4/30, 13%), IGH rearrangement (3/30, 10%) and JAK2 rearrangement (2/30, 7%). All together, Ph-like defining abnormalities comprised 20% of cases. Conclusions: We have validated a rapid and easy test to improve ALL subtype diagnosis, including Ph-like ALL. The panel allowed for 24h-diagnosis in cases without or not assessable metaphases. In conclusion, this panel can be a complementary technique for the immediate identification of most common rearrangements in ALL, particullary those with treatment implications. Disclosures Sanz: Gamida Cell: Research Funding. Solano: Neovii: Honoraria.",
    "topics": [
        "acute lymphocytic leukemia",
        "phosphotransferases",
        "rapid screening test",
        "gene fusion",
        "bcr-abl tyrosine kinase",
        "karyotype determination procedure",
        "chromosome banding",
        "erythropoietin receptors",
        "gene expression profiling",
        "leukemia"
    ],
    "author_names": [
        "Esperanza Such",
        "Gayane Avetisyan",
        "Iv\u00e1n Mart\u00edn",
        "In\u00e9s G\u00f3mez-Segu\u00ed, PhD",
        "Francisca Garc\u00eda",
        "Eva Villam\u00f3n, PhD",
        "Alessandro Liquori, PhD",
        "Francisco Mares, MD",
        "Marta Llop",
        "Paula Amat, MDPhD",
        "Mariam Iba\u00f1ez",
        "Eva Barrag\u00e1n",
        "Mar Tormo, MD PhD",
        "Guillermo Sanz, MD",
        "Carlos Solano, MD PhD",
        "Jos\u00e9 Cervera, MD PhD",
        "Blanca Navarro",
        "Miguel A. Sanz, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Esperanza Such",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Gayane Avetisyan",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Iv\u00e1n Mart\u00edn",
            "author_affiliations": [
                "Hematology Department, Servicio de Hematolog\u00eda, Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "In\u00e9s G\u00f3mez-Segu\u00ed, PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francisca Garc\u00eda",
            "author_affiliations": [
                "Hematology Department, Servicio de Hematolog\u00eda, Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eva Villam\u00f3n, PhD",
            "author_affiliations": [
                "Hematology Department, Servicio de Hematolog\u00eda, Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Liquori, PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francisco Mares, MD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Llop",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paula Amat, MDPhD",
            "author_affiliations": [
                "Hematology Department, Servicio de Hematolog\u00eda, Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mariam Iba\u00f1ez",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eva Barrag\u00e1n",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mar Tormo, MD PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guillermo Sanz, MD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos Solano, MD PhD",
            "author_affiliations": [
                "Hematology Department, Servicio de Hematolog\u00eda, Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jos\u00e9 Cervera, MD PhD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Blanca Navarro",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Miguel A. Sanz, MD",
            "author_affiliations": [
                "Servicio de Hematolog\u00eda. Hospital La Fe, Valencia, Spain, Valencia, Spain ",
                "CIBERONC, Madrid, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-10T15:38:54",
    "is_scraped": "1"
}